Last reviewed · How we verify
NCT04269278
Dexmedetomidine and Blood Coagulation
trial testing 0 ul of dexmedetomidine in Blood Coagulation Disorder in 11 participants. Completed in 30 December 2020.
30 December 2020
Quick facts
| Lead sponsor | Seoul National University Bundang Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 11 |
| Start date | 12 February 2020 |
| Primary completion | 30 December 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- 0 ul of dexmedetomidine — full drug profile →
- 0.25 ul of dexmedetomidine — full drug profile →
- 0.5 ul of dexmedetomidine — full drug profile →
- 0.75 ul of dexmedetomidine — full drug profile →
Conditions studied
- Blood Coagulation Disorder — all drugs for Blood Coagulation Disorder →
Sponsor
Seoul National University Bundang Hospital
Who can join
Adults 20 to 65, any sex, with Blood Coagulation Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dexmedetomidine may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of dexmedetomidine. The investigators have therefore performed the present study to measure the effect of dexmedetomidine on the coagulation pathway according to the drug concentration level using a rotational thromboelastometry test.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of dexmedetomidine on blood coagulation: an in vitro study using rotational thromboelastometry.
Shin HJ, Boo G, Na HS. · · 2021 · cited 2× · PMID 34268623 · DOI 10.1007/s00540-021-02969-x
Verify or expand the search:
- PubMed search for NCT04269278
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Coagulation Disorder
Currently open trials in the same condition.
- NCT07164300 — Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery · NA · recruiting
- NCT06403163 — Transfusion Surveillance in Anaesthesia · recruiting
- NCT03255928 — Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) · recruiting
Other Seoul National University Bundang Hospital trials
Trials by the same sponsor.
- NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
- NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
- NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04269278 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
- Last refreshed: 2 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04269278.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing